Jext®
Epi Pen & Jext Adrenaline Auto-Injectors for Rapid Relief of Allergic Emergencies
EpiPen® Adrenaline Auto-Injector – Life-Saving Emergency Action
The EpiPen® is a revolutionary, single-use auto-injector delivering a fixed dose of epinephrine to treat severe allergic reactions (anaphylaxis). Its simple, intuitive design allows rapid administration into the anterolateral thigh, even over clothing, ensuring fast and reliable response when seconds count
Key Features
-
Two adult and junior strengths:
-
EpiPen® 0.3 mg for adults and children ≥30 kg
-
EpiPen® Jr 0.15 mg for children 15–30 kg
-
150 micrograms if you weigh between 15-30kg
300 micrograms if you weigh over 30kg
Epi-Pen
Epipen
The active ingredient and instructions for use are the same for the EpiPen® and EpiPen® Junior so the information in this website is applicable whether you have been prescribed EpiPen® or EpiPen® Jr and the term EpiPen® used throughout applies to both.
This website provides healthcare professionals with an overview of the treatment of anaphylaxis, the signs and symptoms of an anaphylactic reaction and how to use EpiPen®.
EpiPen® and EpiPen® Jr are indicated in the emergency treatment of severe allergic reactions (anaphylaxis) to insect stings or bites, foods, drugs and other allergens as well as idiopathic or exercise induced anaphylaxis.
Selection of the appropriate dosage strength is determined according to body weight.
EpiPen® auto injectors are automatic injection devices containing adrenaline
for allergic emergencies.

Anyone at risk of an anaphylactic reaction should carry an adrenaline auto-injector with them at all times1, as an immediate injection of adrenaline could be the difference between life and death.
NICE guidelines recommend that all patients admitted with a confirmed or suspected anaphylactic reaction should be prescribed an adrenaline auto-injector while awaiting specialist referral.2
European guidelines provide the following absolute and relative indications for prescribing adrenaline auto-injectors in children.3

